Dr. Andriy Myronenko is a distinguished Senior Research Scientist at NVIDIA, where he leads pioneering work in artificial intelligence applications for medical imaging. Holding a PhD from Oregon Health and Science University (2010), his academic foundation was built on non-rigid image and point set registration methods, establishing the groundwork for his future contributions to medical image analysis. Prior to joining NVIDIA in 2018, he refined his expertise at Accuray Research, developing sophisticated algorithms for deformable registration and segmentation of 3D images for radiotherapy applications. His educational journey began at Dnipropetrovsk National University in Ukraine, where he earned both his Bachelor's and Master's degrees in Computer Science in 2004 and 2005 respectively, demonstrating an early commitment to computational approaches in scientific problem solving.
Dr. Myronenko's pioneering research has significantly advanced the field of medical image analysis through the development of cutting-edge deep learning algorithms for 3D medical image segmentation. His groundbreaking work earned him first place in the largest international challenge of 3D MRI brain tumor segmentation (BraTS) in 2018, establishing his reputation as a leader in the field. Most recently, he has spearheaded the development of NVIDIA's VISTA-2D, an AI Foundation model for cell segmentation with a network architecture of approximately 100 million training hyperparameters, capable of handling diverse imaging modalities including brightfield, phase-contrast, fluorescence, confocal, and electron microscopy. This transformative technology has enabled unprecedented precision in cell morphology analysis, significantly accelerating research in spatial biology and genomics.
Beyond his technical contributions, Dr. Myronenko has established vital collaborations with leading medical institutions including UCSF and Stanford, ensuring that AI technologies become integral components of clinical workflows and directly impact patient care. His work bridges the gap between cutting-edge artificial intelligence research and practical medical applications, fostering a new generation of AI-powered diagnostic tools that enhance both research and clinical practice. Through his continued leadership at NVIDIA, he is driving the development of increasingly sophisticated AI models that promise to revolutionize medical imaging analysis, with ongoing research focused on expanding the capabilities of foundation models in healthcare applications. As the field of medical AI continues to evolve, Dr. Myronenko remains at the forefront, shaping the future of how artificial intelligence transforms healthcare delivery and biomedical research.
